We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid Tests for Chagas Disease Improves Diagnostic Access

By LabMedica International staff writers
Posted on 09 Jul 2025

Chagas disease, caused by the parasite Trypanosoma cruzi, affects between six and seven million people across the Americas. It is primarily transmitted by insect vectors and remains largely underdiagnosed, with less than 1% of those infected receiving treatment. The disease is most commonly diagnosed through serological techniques, which detect antibodies to T. cruzi in the blood during the chronic phase of the disease. However, these methods require specialized personnel and equipment, which are often unavailable in resource-limited areas, making it difficult for people in endemic regions to access proper diagnosis and care. A new approach, combining rapid diagnostic tests (RDTs) with conventional serological techniques, has been proposed to improve access to diagnosis in such settings.

Researchers at the Barcelona Institute for Global Health (ISGlobal, Barcelona, Spain), in collaboration with Paraguayan health authorities, conducted a study involving a screening campaign in an indigenous community in the Paraguayan Chaco, where 999 people were tested. The researchers evaluated the effectiveness of using RDTs for initial screening, followed by confirmation with conventional serological tests such as recombinant and lysate ELISA. The combination of these two methods was found to be highly effective, providing an accessible and rapid solution for diagnosing Chagas disease in remote areas.


Image: Combining rapid diagnostic tests with conventional serology proves to be a useful strategy for diagnosing Chagas disease (Courtesy of Adobe Stock)
Image: Combining rapid diagnostic tests with conventional serology proves to be a useful strategy for diagnosing Chagas disease (Courtesy of Adobe Stock)

The study, published in PLOS Neglected Tropical Diseases, demonstrated that the algorithm using RDTs showed high agreement with the standard algorithm, with a sensitivity of 94.6% and a specificity of 98.6%. The algorithm validated in the study suggests using RDTs for an initial screening of at-risk individuals in endemic areas, thereby reducing the need for serological testing to confirm positive results. The prevalence of the disease was found to be significantly higher in the indigenous community of Casanillo compared to the capital, Asunción, highlighting the health inequalities in urban and rural areas. The researchers plan to further evaluate this approach in other regions and adapt it for broader use in endemic areas to improve access to diagnosis and treatment.

“The results obtained are particularly relevant in the context of a global re-evaluation of guidelines for the diagnosis and treatment of Chagas disease,” said Irene Losada, coordinator of the Chagas Initiative at ISGlobal and senior author of the study. “The adoption of RDT-based algorithms adapted to each region could improve access to diagnosis for thousands of people in remote areas.”

Related Links:
ISGlobal


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Specimen Radiography System
TrueView 200 Pro

Latest Molecular Diagnostics News

Newly-Cleared Technology a Game Changer for Diagnosis of Lyme Disease
08 Jul 2025  |   Molecular Diagnostics

Innovative Liquid Biopsy Test Uses RNA to Detect Early-Stage Cancer
08 Jul 2025  |   Molecular Diagnostics

Simple Blood Test to Predict Alzheimer’s Clinical Progression in Earliest Stages
08 Jul 2025  |   Molecular Diagnostics



PURITAN MEDICAL